Retailer Costco Wholesale Corporation (NASDAQ: COST) reported second-quarter financial results after the market close Thursday. Here are the key highlights.
SVB Leerink analyst David Risinger upgrades Horizon Therapeutics (NASDAQ:HZNP) from Market Perform to Outperform and lowers the price target from $95 to $80.